Management of hepatitis B: summary of a clinical research workshop. - Wikidata - wikimedia - TriplyDB

Management of hepatitis B: summary of a clinical research workshop.

Management of hepatitis B: summary of a clinical research workshop.

http://www.wikidata.org/entity/Q36773747

about

Pharmacological treatments for acute hepatitis B infection: a network meta-analysis Pharmacological treatments for chronic hepatitis B liver disease: a network meta-analysis KASL clinical practice guidelines: management of chronic hepatitis B Hepatocellular carcinoma and hepatitis B surface protein Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation Prevention of hepatocellular carcinoma in patients with chronic hepatitis B Management of chronic hepatitis B in pregnancy Applications of human hepatitis B virus preS domain in bio- and nanotechnology.Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B.Hepatitis B virus and its sexually transmitted infection - an update.Current role of transient elastography in the management of chronic hepatitis B patients Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study.MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG.Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients.Barriers to screening for hepatitis B virus infection in Asian Americans.Intervention strategies for improving patient adherence to follow-up in the era of mobile information technology: a systematic review and meta-analysis.Natural history of chronic hepatitis B: phases in a complex relationship.Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Practical approach in hepatitis B e antigen-negative individuals to identify treatment candidates.Individualized management of pregnant women with high hepatitis B virus DNA levels.HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B.Analysis of precore/core covariances associated with viral kinetics and genotypes in hepatitis B e antigen-positive chronic hepatitis B patients.TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence Evaluation and management of hepatitis B in pregnancy: a survey of current practices Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy.Clinical features of adult patients with acute hepatitis B virus infection progressing to chronic infection.Combination treatment in HBeAg-negative chronic hepatitis B.Current status of antiviral therapy for hepatitis B

P2860

Q24186837-D5C7B09A-0D23-46C4-9A48-3BC46B42B49D Q24186878-57742ED3-775B-45B8-AF20-EE52DE032ECF Q26752475-261CDFD8-2730-49B3-BBDF-99593FBDDE87 Q26766123-B9220E7A-4D99-4888-932C-FD32831F6CD8 Q26772324-56845A65-19FF-4BA4-A00D-AACD80F202A7 Q26784241-AC400161-3BBC-4AE2-A219-0C6BCDEDE50E Q27023997-373C34EC-91B2-4A13-9A6B-F28C591BA699 Q27026593-315962F9-98C8-4C74-9422-21E5AA7E2284 Q27693188-D0730576-EB20-4287-801B-A60023117FB1 Q28480585-AD4F715E-0DB2-4A6B-9EFB-A7CD7DA1ECF3 Q28547647-67B5A578-60CB-49AF-8A6C-06DAE5A84233 Q30220690-8C6170C8-C796-4F06-BE52-C57C1E1CF938 Q30235028-9068CBBB-CCDD-4C4B-A14D-54A98DF43EE9 Q30358894-40BB0FEF-BD38-43E2-A46B-50FC647C604B Q30382346-4B15A399-1F11-43F3-A8C5-9BE7463C8625 Q30400175-44CAE8BA-7C97-448B-ACB3-EF95330525A9 Q33559657-FE9D5FDF-4779-463F-A455-661909F995C7 Q33560668-22864631-4B28-4FFB-86AB-3A0948E34D6E Q33574740-664108D4-E841-4CAB-B84C-7AEDF43CB3E9 Q33619636-4C5810E7-C793-4D44-96AC-C9843F162A33 Q33661037-41A959E9-BF7E-4391-9683-07C4B186F7B3 Q33694522-F6A69210-688F-45B4-BCEE-4A0E31BE0A3A Q33769156-84C0EA39-A53D-49C0-8440-B340AC69AD30 Q33801300-C777DA7C-631D-4E5D-855C-B453CAE2E443 Q33826784-2B3E8BD6-6EB5-4F87-AD79-5DFBFF754778 Q34000950-6DDC1C3A-F8AC-4B21-8FC9-EBF4B72E32F8 Q34011228-D9598B2B-7A32-460C-8788-FCDE41ED8D3D Q34036650-B1DC64AC-ED2E-4CC6-91BB-D5B5E3EAE3C2 Q34106504-54131BE6-338B-4F1F-94CD-D2E2F4D42A61 Q34137291-848A853B-C338-4B50-B838-A575D1FF452B Q34168465-C01EFE23-7B79-4F93-949C-4AF75E3B310E Q34168470-96A842B3-D1B2-4DDA-9D2E-48B5F30140DA Q34169789-BDCA1771-B261-429E-8656-B24D820382EF Q34182782-DE77C47A-E00E-44EA-96B9-95950B9BC166 Q34205905-E748EB7A-F31F-4215-AF6C-FF8BF79347E2 Q34293333-581B93B3-BF83-41B6-A1F8-F37F721ABF6A Q34303163-29F8FF26-2D20-4CCD-A2F3-0C2B8E88A4BA Q34366249-04622D92-94DB-48E8-8B82-83CB80194C90 Q34391476-BFFE0129-C887-4F8F-833D-4DEF22A544C9 Q34408879-F6EEAB6B-DABD-43AF-838F-E61EC2C8B694

P2860

Management of hepatitis B: summary of a clinical research workshop.

http://www.wikidata.org/entity/Q36773747

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Management of hepatitis B: summary of a clinical research workshop.

@ast

Management of hepatitis B: summary of a clinical research workshop.

@en

type

label

Management of hepatitis B: summary of a clinical research workshop.

@ast

Management of hepatitis B: summary of a clinical research workshop.

@en

prefLabel

Management of hepatitis B: summary of a clinical research workshop.

@ast

Management of hepatitis B: summary of a clinical research workshop.

@en

P1433

Q36773747-2BFF79B7-5D12-466C-99EB-28CABA5A3517

P1476

Q36773747-ACE0257D-CC5A-4D16-B434-48462131AFE4

P2093

Q36773747-15C76F54-7645-421D-8F17-273BF610276D

Q36773747-78ADF49A-3678-428F-B025-76F78FD15659

Q36773747-DAF1BAE8-3136-4D56-9916-8B1B4CA15E71

Q36773747-E67C5695-379D-408E-857D-BF9ACC21952C

Q36773747-F7ECF2EB-FD10-4926-8657-F50B6EC7FDBA

P2860

Q36773747-14F4419F-B6F8-4B97-8CC5-0839E2CD6233

Q36773747-1D76C7F3-ED16-4F27-94C5-D5D6026E011E

Q36773747-3BAA4B5B-52A7-4630-AC98-7DAFC8B31EF9

Q36773747-5E44C33F-EDD9-484D-BC5D-C62309BCF6C5

Q36773747-794D8F6D-2CBC-4FBE-8C90-DA3DBA70F344

Q36773747-ACB1CA01-F7F1-408A-9EF7-18019D7812D1

Q36773747-B93B9915-4963-4D5E-83C6-8C38D47B299B

Q36773747-C5872151-D2A9-4102-AC7C-48CAE64056C4

Q36773747-E3AF1DB0-D19B-45BE-BD46-0142CADE701E

P304

Q36773747-6C3804A0-2491-4207-9D75-223498C9A980

P31

Q36773747-D52E7C30-8430-4EB4-8481-D8A67DEA9585

P356

Q36773747-2FF30A62-ECE8-4172-8477-44787A826A8E

P407

Q36773747-29788954-C52B-4D14-90F7-9ADD5D61E456

P433

Q36773747-92C1A5D6-FC83-4598-A845-40BABF6414C7

P478

Q36773747-E474528A-C132-4008-B771-84E642F5B128

P577

Q36773747-E8FED778-F1ED-4E11-A302-0C2855E0B15A

P5875

Q36773747-53A46594-EA77-4EDD-AF72-11148B1E97E5

P698

Q36773747-4A106401-3236-4743-8A6A-4A8E8117374B

P921

Q36773747-490C3028-2732-4799-81C2-D47B31CDEAF6

P356

P1433

P1476

Management of hepatitis B: summary of a clinical research workshop.

@en

P2093

Anna S F Lok

http://www.w3.org/2001/XMLSchema#string

Edward Doo

http://www.w3.org/2001/XMLSchema#string

Jay H Hoofnagle

http://www.w3.org/2001/XMLSchema#string

Russell Fleischer

http://www.w3.org/2001/XMLSchema#string

T Jake Liang

http://www.w3.org/2001/XMLSchema#string

P2860

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo.

Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies.

Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis.

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy.

Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type 1.

Sampling variability of liver fibrosis in chronic hepatitis C.

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

P304

1056-1075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.21627

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51376958

http://www.w3.org/2001/XMLSchema#string

P698

17393513

http://www.w3.org/2001/XMLSchema#string

P921